Business

Mass. Movers

Harvard Bioscience stock

Harvard Bioscience develops tools for life-sciences research and regenerative medicine.
Essdras M Suarez/Globe Staff/File 2011
Harvard Bioscience develops tools for life-sciences research and regenerative medicine.

Harvard Bioscience Inc.’s shares rose 11 cents to $5.01. It’s board of directors this week elected Jeffrey A. Duchemin as chief executive of the Holliston company. The interim CEO, David Green, will continue as president until the spin-off of the regenerative medicine subsidiary, which Green will head. Most recently, Duchemin was global business director for Corning Life Sciences.

Advertisement